CompoAtlas

Leptiburn

Natural health product licensed in Canada

Licence holder
Bio Trust Nutrition LLC.
NPN or DIN-HM
80046458
Status
Inactive licence
Licence date
25 November 2013
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Non traditionnelle

If this product were sold in France

No point flagged by the rules we apply.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Ilex paraguariensis

Source : Feuille

Extraction ratio : 10:1

Dry plant equivalent : 293.6 mg

Potency : 0.31 mg Caffeine

29.36 mgNot calculated
Laminaria japonica

Source : En entier

Extraction ratio : 8:1

Dry plant equivalent : 800 mg

Potency : 5 % Fucoxanthin

100 mgNot calculated
Panax notoginseng

Source : Racine

Extraction ratio : 4:1

Dry plant equivalent : 800 mg

Potency : 5 % Ginsenosides

200 mgNot calculated

Non-medicinal ingredients

Acide stéarique, Cellulose

PopulationAgeQuantity per servingFrequency
AdultesNot specified2 Capsule2 days

Uses authorised in Canada

Green tea extract and yerba mate are sources of caffeine, which helps to temporarily increase basal metabolic rate/thermogenesis. Olive leaf extract provides antioxidants.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80046458

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line